Arrowhead Pharmaceuticals, Inc. (ARWR)

Arrowhead Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Cash & Equivalents	67.2	102.99	100.71	184.43	143.58	221.8
Short-Term Investments	367.27	292.74	268.39	183.36	171.91	36.9
Cash & Short-Term Investments	434.47	395.73	369.1	367.79	315.49	258.7
Cash Growth	-2.23%	7.21%	0.36%	16.58%	21.95%	238.03%
Receivables	-	-	1.41	10.26	0.85	0.66
Prepaid Expenses	9.21	8.81	7.29	4.36	4.25	3.32
Restricted Cash	2.2	7.9	7.3	-	-	-
Other Current Assets	4.18	7.08	20.2	2.19	1.78	2.56
Total Current Assets	450.06	419.52	405.3	384.6	322.37	265.25
Property, Plant & Equipment	420.25	335.56	168.59	66.02	47.02	23.21
Long-Term Investments	-	-	105.87	245.6	137.49	44.18
Other Intangible Assets	8.99	10.26	11.96	13.66	15.36	17.06
Other Long-Term Assets	4.46	0.21	0.22	0.27	0.26	0.14
Total Assets	883.76	765.55	691.94	710.15	522.5	349.85
Accounts Payable	26.55	35.87	2.87	9.46	6.83	7.65
Accrued Expenses	63.69	57.73	59.11	23.77	13.45	11.46
Current Portion of Leases	6.05	10.56	2.78	2.25	1.1	-
Current Unearned Revenue	-	0.87	74.1	111.06	19.29	77.77
Other Current Liabilities	0.42	0.44	-	-	0.02	0.19
Total Current Liabilities	96.71	105.46	138.85	146.54	40.68	97.07
Long-Term Debt	336.03	268.33	-	-	-	-
Long-Term Leases	112.04	104.61	78.8	23.3	20.04	-
Long-Term Unearned Revenue	-	-	55.95	131.5	-	5.04
Other Long-Term Liabilities	-	-	-	-	-	3.7
Total Liabilities	544.79	478.39	273.6	301.33	60.73	105.81
Common Stock	0.22	0.2	0.2	0.2	0.2	0.19
Additional Paid-In Capital	1,786	1,300	1,219	1,053	965.41	664.09
Retained Earnings	-1,455	-1,026	-820.76	-644.69	-503.84	-419.29
Comprehensive Income & Other	-0.99	-3.22	-0.14	-0.07	0.02	-0.39
Total Common Equity	330.55	271.34	398.52	408.82	461.78	244.59
Minority Interest	8.43	15.82	19.82	-	-	-0.56
Shareholders' Equity	338.97	287.16	418.34	408.82	461.78	244.04
Total Liabilities & Equity	883.76	765.55	691.94	710.15	522.5	349.85
Total Debt	454.12	383.5	81.58	25.55	21.14	-
Net Cash (Debt)	-19.65	12.23	287.52	342.24	294.36	258.7
Net Cash Growth	-	-95.75%	-15.99%	16.27%	13.78%	248.62%
Net Cash Per Share	-0.17	0.11	2.73	3.30	2.92	2.62
Filing Date Shares Outstanding	124.32	107.43	106.01	104.53	102.76	95.71
Total Common Shares Outstanding	124.23	107.31	105.96	104.33	102.38	95.51
Working Capital	353.35	314.07	266.45	238.06	281.69	168.18
Book Value Per Share	2.66	2.53	3.76	3.92	4.51	2.56
Tangible Book Value	321.56	261.08	386.56	395.16	446.42	227.53
Tangible Book Value Per Share	2.59	2.43	3.65	3.79	4.36	2.38
Land	3	3	3	-	-	-
Machinery	70.78	58.75	40.47	29.67	21.32	13.57
Construction In Progress	175.78	166.66	56.37	0.35	-	-
Leasehold Improvements	104.4	103.81	42.02	41.52	25.24	21.58

Source: S&P Capital IQ. Standard template. Financial Sources.